 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - SpringWorks Therapeutics Inc. (SWTX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-19 Sale | 2021-01-21 4:30 pm | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 62,500 | $78.55 | $4,909,390 | 1,222,997 (Direct) | View |
| 2021-01-20 Sale | 2021-01-21 4:31 pm | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $78.7 | $787,016 | 167,511 (Direct) | View |
| 2021-01-25 Sale | 2021-01-26 4:31 pm | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin COO | 32,000 | $84.07 | $2,690,281 | 261,542 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 6:55 pm | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 1,220,000 | $83.19 | $101,491,803 | 6,186,307 (Indirect) | View |
| 2021-03-09 Sale | 2021-03-11 4:30 pm | SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 1,450,000 | $71.5 | $103,675,000 | 5,831,307 (Indirect) | View |
| 2021-04-13 Sale | 2021-04-13 8:21 pm | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $68.07 | $680,723 | 167,511 (Direct) | View |
| 2021-04-14 Sale | 2021-04-19 06:07 am | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 1,568 | $75.04 | $117,655 | 145,160 (Direct) | View |
| 2021-04-19 Sale | 2021-04-20 6:51 pm | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 62,500 | $68.02 | $4,251,106 | 884,052 (Direct) | View |
| 2021-04-27 Sale | 2021-04-28 8:18 pm | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 19,432 | $76.19 | $1,480,522 | 125,728 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 6:26 pm | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 48,053 | $85.36 | $4,101,908 | 6,138,254 (Indirect) | View |
| 2021-06-10 Sale | 2021-06-14 5:58 pm | SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 30,852 | $85.09 | $2,625,197 | 6,107,402 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-02 Option Award | 2020-03-04 6:20 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Business Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:21 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Renstrup Jens Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:21 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr CFO | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:22 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:23 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-13 4:01 pm | N/A 2030-03-12 | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:16 pm | N/A 2030-05-20 | SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner | 7,464 | $0 | 7,464 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:34 pm | N/A 2030-05-20 | SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director | 14,668 | $0 | 14,668 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:37 pm | N/A 2030-05-20 | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner | 7,464 | $0 | 7,464 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:37 pm | N/A 2030-05-20 | SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director 10% Owner | 7,464 | $0 | 7,464 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:38 pm | N/A 2030-05-20 | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 7,464 | $0 | 7,464 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:38 pm | N/A 2030-05-20 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 7,464 | $0 | 7,464 (Direct) | View |
| 2020-08-03 Option Award | 2020-08-05 6:08 pm | N/A 2030-08-03 | SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:28 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin COO | 13,000 | $0 | 293,542 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:28 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin COO | 104,000 | $0 | 104,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:28 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 37,500 | $0 | 1,285,497 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:28 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Islam Saqib CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:29 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Nofi Michael CAO | 3,000 | $0 | 3,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:29 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Nofi Michael CAO | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr CFO | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr CFO | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer | 4,150 | $0 | 4,150 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer | 33,200 | $0 | 33,200 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Renstrup Jens Chief Medical Officer | 6,075 | $0 | 250,499 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Renstrup Jens Chief Medical Officer | 48,600 | $0 | 48,600 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 11,000 | $0 | 167,511 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 88,000 | $0 | 88,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:31 am | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel and Secretary | 7,000 | $0 | 7,000 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:31 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel and Secretary | 56,000 | $0 | 56,000 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 4:31 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,128 | $1.65 | 168,639 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 4:31 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 8,872 | $2.3 | 177,511 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 4:31 pm | N/A 2029-03-19 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,128 | $0 | 1,451 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 4:31 pm | N/A 2029-04-22 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 8,872 | $0 | 114,296 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-01 5:37 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-01 5:37 pm | N/A 2031-04-01 | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 92,000 | $0 | 92,000 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 8:21 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $2.3 | 177,511 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 8:21 pm | N/A 2029-04-22 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $0 | 104,296 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:31 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 1,106 | $0 | 126,834 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:31 pm | N/A 2031-05-20 | SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner | 6,998 | $0 | 6,998 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:31 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director | 1,106 | $0 | 292,383 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:31 pm | N/A 2031-05-20 | SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director | 6,998 | $0 | 6,998 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:32 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director | 1,106 | $0 | 25,227 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:32 pm | N/A 2031-05-20 | SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director | 6,998 | $0 | 6,998 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:32 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director | 1,106 | $0 | 5,995 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:32 pm | N/A 2031-05-20 | SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director | 6,998 | $0 | 6,998 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:32 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 1,106 | $0 | 25,227 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:32 pm | N/A 2031-05-20 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 6,998 | $0 | 6,998 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 5:45 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner | 1,106 | $0 | 1,106 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 5:45 pm | N/A 2031-05-20 | SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner | 6,998 | $0 | 6,998 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-01 5:25 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development | 27,500 | $0 | 27,500 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-01 5:25 pm | N/A 2031-06-01 | SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development | 225,000 | $0 | 225,000 (Direct) | View |